Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

about

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

Item

http://www.wikidata.org/entity/Q66402700

description

clinical trial

@en

klinisch onderzoek

@nl

name

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

@en

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

@nl

type

Item

label

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

@en

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

@nl

prefLabel

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

@en

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

@nl

P1476

A Phase I, Double-Blind, Dose ...... ntravenously in Healthy Adults

@en

P17

Ameeriga Ütisriigiq

P2899

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT02779140

http://www.w3.org/2001/XMLSchema#string

P31

clinical trial

P4135

http://www.w3.org/2001/XMLSchema#decimal

P580

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase I clinical trial